By vgreene, 28 October, 2021 FDA MedWatch Hydroxychloroquine or Chloroquine for COVID 19 Drug Safety Communication FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems see FDA alert
By vgreene, 28 October, 2021 Proposed mechanism inhibits viral entry and replication via intracellular alkalinization interferes w maturation of viral particles through impaired glycosylation indirect immunomodulatory effects
By vgreene, 28 October, 2021 Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized With Covid 19 full text Med article
By vgreene, 28 October, 2021 Hydroxychloroquine and Azithromycin as a Treatment of COVID 19 Results of an Open Label Non randomized Clinical Trial full text Int J Antimicrob Agents article
By vgreene, 28 October, 2021 Clinical Efficacy of Hydroxychloroquine in Patients With COVID 19 Pneumonia Who Require Oxygen Observational Comparative Study Using Routine Care Data full text BMJ article
